 | • レポートコード：MRC2012A1858 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、CD40リガンドの世界市場を広く調査・分析し、今後の市場展望をまとめております。CD40リガンドの種類別市場規模（ISF-35、LOAd-700、MEDI-4920、MegaCD40L、その他）、用途別市場規模（B型肝炎、膀胱がん、肝臓がん、卵巣がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Biogen, Inc.、XL-protein GmbH、ImmuNext, Inc.、Bristol-Myers Squibb Company、Targovax AS、eTheRNA Immunotherapies NV、MedImmune, LLC、Juno Therapeutics Inc.、 ・地域別グローバル市場分析 2015年-2020年 ・CD40リガンドの北米市場（アメリカ、カナダ、メキシコ） ・CD40リガンドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・CD40リガンドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・CD40リガンドの南米市場（ブラジル、アルゼンチン） ・CD40リガンドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ISF-35、LOAd-700、MEDI-4920、MegaCD40L、その他 ・用途別分析：B型肝炎、膀胱がん、肝臓がん、卵巣がん、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global CD40 Ligand market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The CD40 Ligand market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
CD40 Ligand market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, CD40 Ligand market has been segmented into
ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others
By Application, CD40 Ligand has been segmented into:
Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global CD40 Ligand market presented in the report. This section sheds light on the sales growth of different regional and country-level CD40 Ligand markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CD40 Ligand market.
The report offers in-depth assessment of the growth and other aspects of the CD40 Ligand market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and CD40 Ligand Market Share Analysis
CD40 Ligand competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CD40 Ligand sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CD40 Ligand sales, revenue and market share for each player covered in this report.
The major players covered in CD40 Ligand are:
Biogen, Inc.
XL-protein GmbH
ImmuNext, Inc.
Bristol-Myers Squibb Company
Targovax AS
eTheRNA Immunotherapies NV
MedImmune, LLC
Juno Therapeutics Inc.
Among other players domestic and global, CD40 Ligand market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe CD40 Ligand product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of CD40 Ligand, with price, sales, revenue and global market share of CD40 Ligand in 2018 and 2019.
Chapter 3, the CD40 Ligand competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CD40 Ligand breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, CD40 Ligand market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe CD40 Ligand sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 CD40 Ligand Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global CD40 Ligand Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ISF-35
1.2.3 LOAd-700
1.2.4 MEDI-4920
1.2.5 MegaCD40L
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global CD40 Ligand Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hepatitis B
1.3.3 Bladder Cancer
1.3.4 Liver Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Overview of Global CD40 Ligand Market
1.4.1 Global CD40 Ligand Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Biogen, Inc.
2.1.1 Biogen, Inc. Details
2.1.2 Biogen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biogen, Inc. SWOT Analysis
2.1.4 Biogen, Inc. Product and Services
2.1.5 Biogen, Inc. CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 XL-protein GmbH
2.2.1 XL-protein GmbH Details
2.2.2 XL-protein GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 XL-protein GmbH SWOT Analysis
2.2.4 XL-protein GmbH Product and Services
2.2.5 XL-protein GmbH CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 ImmuNext, Inc.
2.3.1 ImmuNext, Inc. Details
2.3.2 ImmuNext, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 ImmuNext, Inc. SWOT Analysis
2.3.4 ImmuNext, Inc. Product and Services
2.3.5 ImmuNext, Inc. CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb Company SWOT Analysis
2.4.4 Bristol-Myers Squibb Company Product and Services
2.4.5 Bristol-Myers Squibb Company CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Targovax AS
2.5.1 Targovax AS Details
2.5.2 Targovax AS Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Targovax AS SWOT Analysis
2.5.4 Targovax AS Product and Services
2.5.5 Targovax AS CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 eTheRNA Immunotherapies NV
2.6.1 eTheRNA Immunotherapies NV Details
2.6.2 eTheRNA Immunotherapies NV Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 eTheRNA Immunotherapies NV SWOT Analysis
2.6.4 eTheRNA Immunotherapies NV Product and Services
2.6.5 eTheRNA Immunotherapies NV CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 MedImmune, LLC
2.7.1 MedImmune, LLC Details
2.7.2 MedImmune, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 MedImmune, LLC SWOT Analysis
2.7.4 MedImmune, LLC Product and Services
2.7.5 MedImmune, LLC CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Juno Therapeutics Inc.
2.8.1 Juno Therapeutics Inc. Details
2.8.2 Juno Therapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Juno Therapeutics Inc. SWOT Analysis
2.8.4 Juno Therapeutics Inc. Product and Services
2.8.5 Juno Therapeutics Inc. CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global CD40 Ligand Sales and Market Share by Manufacturer (2018-2019)
3.2 Global CD40 Ligand Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 CD40 Ligand Manufacturer Market Share in 2019
3.3.2 Top 6 CD40 Ligand Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global CD40 Ligand Sales, Revenue and Market Share by Regions
4.1.1 Global CD40 Ligand Sales and Market Share by Regions (2015-2020)
4.1.2 Global CD40 Ligand Revenue and Market Share by Regions (2015-2020)
4.2 North America CD40 Ligand Sales and Growth Rate (2015-2020)
4.3 Europe CD40 Ligand Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific CD40 Ligand Sales and Growth Rate (2015-2020)
4.5 South America CD40 Ligand Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa CD40 Ligand Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America CD40 Ligand Sales, Revenue and Market Share by Country
5.1.1 North America CD40 Ligand Sales and Market Share by Country (2015-2020)
5.1.2 North America CD40 Ligand Revenue and Market Share by Country (2015-2020)
5.2 United States CD40 Ligand Sales and Growth Rate (2015-2020)
5.3 Canada CD40 Ligand Sales and Growth Rate (2015-2020)
5.4 Mexico CD40 Ligand Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe CD40 Ligand Sales, Revenue and Market Share by Country
6.1.1 Europe CD40 Ligand Sales and Market Share by Country (2015-2020)
6.1.2 Europe CD40 Ligand Revenue and Market Share by Country (2015-2020)
6.2 Germany CD40 Ligand Sales and Growth Rate (2015-2020)
6.3 UK CD40 Ligand Sales and Growth Rate (2015-2020)
6.4 France CD40 Ligand Sales and Growth Rate (2015-2020)
6.5 Russia CD40 Ligand Sales and Growth Rate (2015-2020)
6.6 Italy CD40 Ligand Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific CD40 Ligand Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific CD40 Ligand Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific CD40 Ligand Revenue and Market Share by Regions (2015-2020)
7.2 China CD40 Ligand Sales and Growth Rate (2015-2020)
7.3 Japan CD40 Ligand Sales and Growth Rate (2015-2020)
7.4 Korea CD40 Ligand Sales and Growth Rate (2015-2020)
7.5 India CD40 Ligand Sales and Growth Rate (2015-2020)
7.6 Southeast Asia CD40 Ligand Sales and Growth Rate (2015-2020)
7.7 Australia CD40 Ligand Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America CD40 Ligand Sales, Revenue and Market Share by Country
8.1.1 South America CD40 Ligand Sales and Market Share by Country (2015-2020)
8.1.2 South America CD40 Ligand Revenue and Market Share by Country (2015-2020)
8.2 Brazil CD40 Ligand Sales and Growth Rate (2015-2020)
8.3 Argentina CD40 Ligand Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa CD40 Ligand Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa CD40 Ligand Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa CD40 Ligand Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia CD40 Ligand Sales and Growth Rate (2015-2020)
9.3 Turkey CD40 Ligand Sales and Growth Rate (2015-2020)
9.4 Egypt CD40 Ligand Sales and Growth Rate (2015-2020)
9.5 South Africa CD40 Ligand Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global CD40 Ligand Sales and Market Share by Type (2015-2020)
10.2 Global CD40 Ligand Revenue and Market Share by Type (2015-2020)
10.3 Global CD40 Ligand Price by Type (2015-2020)
11 Global CD40 Ligand Market Segment by Application
11.1 Global CD40 Ligand Sales Market Share by Application (2015-2020)
11.2 Global CD40 Ligand Revenue Market Share by Application (2015-2020)
11.3 Global CD40 Ligand Price by Application (2015-2020)
12 Market Forecast
12.1 Global CD40 Ligand Sales, Revenue and Growth Rate (2021-2025)
12.2 CD40 Ligand Market Forecast by Regions (2021-2025)
12.2.1 North America CD40 Ligand Market Forecast (2021-2025)
12.2.2 Europe CD40 Ligand Market Forecast (2021-2025)
12.2.3 Asia-Pacific CD40 Ligand Market Forecast (2021-2025)
12.2.4 South America CD40 Ligand Market Forecast (2021-2025)
12.2.5 Middle East & Africa CD40 Ligand Market Forecast (2021-2025)
12.3 CD40 Ligand Market Forecast by Type (2021-2025)
12.3.1 Global CD40 Ligand Sales Forecast by Type (2021-2025)
12.3.2 Global CD40 Ligand Market Share Forecast by Type (2021-2025)
12.4 CD40 Ligand Market Forecast by Application (2021-2025)
12.4.1 Global CD40 Ligand Sales Forecast by Application (2021-2025)
12.4.2 Global CD40 Ligand Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global CD40 Ligand Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of CD40 Ligand by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global CD40 Ligand Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Biogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Biogen, Inc. CD40 Ligand Major Business
Table 9. Biogen, Inc. CD40 Ligand Total Revenue (USD Million) (2017-2018)
Table 10. Biogen, Inc. SWOT Analysis
Table 11. Biogen, Inc. CD40 Ligand Product and Services
Table 12. Biogen, Inc. CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. XL-protein GmbH Basic Information, Manufacturing Base and Competitors
Table 14. XL-protein GmbH CD40 Ligand Major Business
Table 15. XL-protein GmbH CD40 Ligand Total Revenue (USD Million) (2017-2018)
Table 16. XL-protein GmbH SWOT Analysis
Table 17. XL-protein GmbH CD40 Ligand Product and Services
Table 18. XL-protein GmbH CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. ImmuNext, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. ImmuNext, Inc. CD40 Ligand Major Business
Table 21. ImmuNext, Inc. CD40 Ligand Total Revenue (USD Million) (2017-2018)
Table 22. ImmuNext, Inc. SWOT Analysis
Table 23. ImmuNext, Inc. CD40 Ligand Product and Services
Table 24. ImmuNext, Inc. CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 26. Bristol-Myers Squibb Company CD40 Ligand Major Business
Table 27. Bristol-Myers Squibb Company CD40 Ligand Total Revenue (USD Million) (2017-2018)
Table 28. Bristol-Myers Squibb Company SWOT Analysis
Table 29. Bristol-Myers Squibb Company CD40 Ligand Product and Services
Table 30. Bristol-Myers Squibb Company CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Targovax AS Basic Information, Manufacturing Base and Competitors
Table 32. Targovax AS CD40 Ligand Major Business
Table 33. Targovax AS CD40 Ligand Total Revenue (USD Million) (2017-2018)
Table 34. Targovax AS SWOT Analysis
Table 35. Targovax AS CD40 Ligand Product and Services
Table 36. Targovax AS CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. eTheRNA Immunotherapies NV Basic Information, Manufacturing Base and Competitors
Table 38. eTheRNA Immunotherapies NV CD40 Ligand Major Business
Table 39. eTheRNA Immunotherapies NV CD40 Ligand Total Revenue (USD Million) (2017-2018)
Table 40. eTheRNA Immunotherapies NV SWOT Analysis
Table 41. eTheRNA Immunotherapies NV CD40 Ligand Product and Services
Table 42. eTheRNA Immunotherapies NV CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. MedImmune, LLC Basic Information, Manufacturing Base and Competitors
Table 44. MedImmune, LLC CD40 Ligand Major Business
Table 45. MedImmune, LLC CD40 Ligand Total Revenue (USD Million) (2017-2018)
Table 46. MedImmune, LLC SWOT Analysis
Table 47. MedImmune, LLC CD40 Ligand Product and Services
Table 48. MedImmune, LLC CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Juno Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 50. Juno Therapeutics Inc. CD40 Ligand Major Business
Table 51. Juno Therapeutics Inc. CD40 Ligand Total Revenue (USD Million) (2017-2018)
Table 52. Juno Therapeutics Inc. SWOT Analysis
Table 53. Juno Therapeutics Inc. CD40 Ligand Product and Services
Table 54. Juno Therapeutics Inc. CD40 Ligand Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global CD40 Ligand Sales by Manufacturer (2018-2019) (K Pcs)
Table 56. Global CD40 Ligand Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global CD40 Ligand Sales by Regions (2015-2020) (K Pcs)
Table 58. Global CD40 Ligand Sales Market Share by Regions (2015-2020)
Table 59. Global CD40 Ligand Revenue by Regions (2015-2020) (USD Million)
Table 60. North America CD40 Ligand Sales by Countries (2015-2020) (K Pcs)
Table 61. North America CD40 Ligand Sales Market Share by Countries (2015-2020)
Table 62. North America CD40 Ligand Revenue by Countries (2015-2020) (USD Million)
Table 63. North America CD40 Ligand Revenue Market Share by Countries (2015-2020)
Table 64. Europe CD40 Ligand Sales by Countries (2015-2020) (K Pcs)
Table 65. Europe CD40 Ligand Sales Market Share by Countries (2015-2020)
Table 66. Europe CD40 Ligand Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific CD40 Ligand Sales by Regions (2015-2020) (K Pcs)
Table 68. Asia-Pacific CD40 Ligand Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific CD40 Ligand Revenue by Regions (2015-2020) (USD Million)
Table 70. South America CD40 Ligand Sales by Countries (2015-2020) (K Pcs)
Table 71. South America CD40 Ligand Sales Market Share by Countries (2015-2020)
Table 72. South America CD40 Ligand Revenue by Countries (2015-2020) (USD Million)
Table 73. South America CD40 Ligand Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa CD40 Ligand Sales by Countries (2015-2020) (K Pcs)
Table 75. Middle East & Africa CD40 Ligand Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa CD40 Ligand Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa CD40 Ligand Revenue Market Share by Countries (2015-2020)
Table 78. Global CD40 Ligand Sales by Type (2015-2020) (K Pcs)
Table 79. Global CD40 Ligand Sales Share by Type (2015-2020)
Table 80. Global CD40 Ligand Revenue by Type (2015-2020) (USD Million)
Table 81. Global CD40 Ligand Revenue Share by Type (2015-2020)
Table 82. Global CD40 Ligand Sales by Application (2015-2020) (K Pcs)
Table 83. Global CD40 Ligand Sales Share by Application (2015-2020)
Table 84. Global CD40 Ligand Sales Forecast by Regions (2021-2025) (K Pcs)
Table 85. Global CD40 Ligand Market Share Forecast by Regions (2021-2025)
Table 86. Global CD40 Ligand Sales Forecast by Type (2021-2025) (K Pcs)
Table 87. Global CD40 Ligand Market Share Forecast by Type (2021-2025)
Table 88. Global CD40 Ligand Sales Forecast by Application (2021-2025)
Table 89. Global CD40 Ligand Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. CD40 Ligand Picture
Figure 2. Global Sales Market Share of CD40 Ligand by Type in 2019
Figure 3. ISF-35 Picture
Figure 4. LOAd-700 Picture
Figure 5. MEDI-4920 Picture
Figure 6. MegaCD40L Picture
Figure 7. Others Picture
Figure 8. CD40 Ligand Sales Market Share by Application in 2018
Figure 9. Hepatitis B Picture
Figure 10. Bladder Cancer Picture
Figure 11. Liver Cancer Picture
Figure 12. Ovarian Cancer Picture
Figure 13. Others Picture
Figure 14. Global CD40 Ligand Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia CD40 Ligand Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey CD40 Ligand Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global CD40 Ligand Sales Market Share by Manufacturer in 2019
Figure 35. Global CD40 Ligand Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 CD40 Ligand Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 CD40 Ligand Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global CD40 Ligand Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global CD40 Ligand Revenue Market Share by Regions (2015-2020)
Figure 42. Global CD40 Ligand Revenue Market Share by Regions in 2018
Figure 43. North America CD40 Ligand Sales and Growth Rate (2015-2020)
Figure 44. Europe CD40 Ligand Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific CD40 Ligand Sales and Growth Rate (2015-2020)
Figure 46. South America CD40 Ligand Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa CD40 Ligand Sales and Growth Rate (2015-2020)
Figure 48. North America CD40 Ligand Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America CD40 Ligand Sales Market Share by Countries (2015-2020)
Figure 50. North America CD40 Ligand Sales Market Share by Countries in 2018
Figure 51. North America CD40 Ligand Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America CD40 Ligand Revenue Market Share by Countries in 2018
Figure 53. United States CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe CD40 Ligand Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe CD40 Ligand Revenue Market Share by Countries (2015-2020)
Figure 58. Europe CD40 Ligand Revenue Market Share by Countries in 2019
Figure 59. Germany CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific CD40 Ligand Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific CD40 Ligand Sales Market Share by Regions 2019
Figure 66. Asia-Pacific CD40 Ligand Revenue Market Share by Regions 2019
Figure 67. China CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America CD40 Ligand Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America CD40 Ligand Sales Market Share by Countries in 2019
Figure 74. South America CD40 Ligand Revenue Market Share by Countries in 2019
Figure 75. Brazil CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa CD40 Ligand Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa CD40 Ligand Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa CD40 Ligand Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa CD40 Ligand Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa CD40 Ligand Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global CD40 Ligand Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global CD40 Ligand Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales CD40 Ligand Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales CD40 Ligand Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales CD40 Ligand Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales CD40 Ligand Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales CD40 Ligand Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
CD40リガンドの世界市場（～2026年） Market Analysis and Insights: Global CD40 Ligand Market The global CD40 Ligand market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global CD40 Ligand Scope and Market Size CD40 Ligand market is segmented by Type, and by Applicati…- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 卵巣がんの世界市場（～2026年） Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. North America dominates the global market for ovarian cancer due to large number of aging …
- 卵巣がん治療薬の世界市場（～2026年） Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products. Market Analysis and Insights: Global…
- 膀胱がん治療・診断の世界市場（～2026年） The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…